Literature DB >> 21042869

Cytotoxic and EGFR tyrosine kinase inhibitory activities of aglycone derivatives obtained by enzymatic hydrolysis of oleoside-type secoiridoid glucosides, oleuropein and ligustroside.

Masafumi Kikuchi1, Nariyasu Mano, Yoshimasa Uehara, Koichi Machida, Masao Kikuchi.   

Abstract

Hydrolysis of oleoside-type secoiridoid glucosides, oleuropein (1) and ligustroside (2), in the presence of β-glucosidase provided their aglycones, named (5S,8R,9S)-7-3,4-dihydroxyphenethyl elenolate (3) and (5S,8R,9S)-7-4-hydroxyphenethyl elenolate (4), respectively. The structures of 3 and 4 were identified by spectroscopic means and optical rotation measurements. Evaluation of the cytotoxic and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitory activities of compounds 1-4 showed that compounds 3 and 4 exhibited moderate cytotoxicity against a disease-oriented panel of 39 human cancer cell lines in vitro, whereas compound 3 inhibited the enzyme.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21042869     DOI: 10.1007/s11418-010-0476-8

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  9 in total

1.  Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.

Authors:  T Yamori; A Matsunaga; S Sato; K Yamazaki; A Komi; K Ishizu; I Mita; H Edatsugi; Y Matsuba; K Takezawa; O Nakanishi; H Kohno; Y Nakajima; H Komatsu; T Andoh; T Tsuruo
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

2.  Correlating phosphatidylinositol 3-kinase inhibitor efficacy with signaling pathway status: in silico and biological evaluations.

Authors:  Shingo Dan; Mutsumi Okamura; Mariko Seki; Kanami Yamazaki; Hironobu Sugita; Michiyo Okui; Yumiko Mukai; Hiroyuki Nishimura; Reimi Asaka; Kimie Nomura; Yuichi Ishikawa; Takao Yamori
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Highlights in oleuropein aglycone structure.

Authors:  Marcella Guiso; Carolina Marra
Journal:  Nat Prod Res       Date:  2005-02       Impact factor: 2.861

4.  Separation and identification of phenolic compounds in olive oil by coupling high-performance liquid chromatography with postcolumn solid-phase extraction to nuclear magnetic resonance spectroscopy (LC-SPE-NMR).

Authors:  Stella Christophoridou; Photis Dais; Li-Hong Tseng; Manfred Spraul
Journal:  J Agric Food Chem       Date:  2005-06-15       Impact factor: 5.279

5.  Structure and cytotoxic activity of enzymatic hydrolysis products of secoiridoid glucosides, isoligustroside and isooleuropein.

Authors:  Masafumi Kikuchi; Yasunori Yaoita; Nariyasu Mano; Masao Kikuchi
Journal:  Chem Biodivers       Date:  2011-04       Impact factor: 2.408

6.  In vitro cytotoxicity to human cells in culture of some phenolics from olive oil.

Authors:  H Babich; F Visioli
Journal:  Farmaco       Date:  2003-05

Review 7.  Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?

Authors:  Nicola Normanno; Monica R Maiello; Antonella De Luca
Journal:  J Cell Physiol       Date:  2003-01       Impact factor: 6.384

8.  Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation.

Authors:  Roberto Fabiani; Angelo De Bartolomeo; Patrizia Rosignoli; Maurizio Servili; Roberto Selvaggini; Gian Francesco Montedoro; Cristina Di Saverio; Guido Morozzi
Journal:  J Nutr       Date:  2006-03       Impact factor: 4.798

9.  tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO).

Authors:  Javier A Menendez; Alejandro Vazquez-Martin; Rocio Garcia-Villalba; Alegria Carrasco-Pancorbo; Cristina Oliveras-Ferraros; Alberto Fernandez-Gutierrez; Antonio Segura-Carretero
Journal:  BMC Cancer       Date:  2008-12-18       Impact factor: 4.430

  9 in total
  3 in total

1.  Novel c-Met inhibitory olive secoiridoid semisynthetic analogs for the control of invasive breast cancer.

Authors:  Mohamed M Mohyeldin; Belnaser A Busnena; Mohamed R Akl; Ana Maria Dragoi; James A Cardelli; Khalid A El Sayed
Journal:  Eur J Med Chem       Date:  2016-08-08       Impact factor: 6.514

2.  Novel liquid-liquid extraction and self-emulsion methods for simplified isolation of extra-virgin olive oil phenolics with emphasis on (-)-oleocanthal and its oral anti-breast cancer activity.

Authors:  Abu Bakar Siddique; Hassan Ebrahim; Mohamed Mohyeldin; Mohammed Qusa; Yazan Batarseh; Ahmed Fayyad; Afsana Tajmim; Sami Nazzal; Amal Kaddoumi; Khalid El Sayed
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

Review 3.  Potential Uses of Olive Oil Secoiridoids for the Prevention and Treatment of Cancer: A Narrative Review of Preclinical Studies.

Authors:  Maria Rita Emma; Giuseppa Augello; Vita Di Stefano; Antonina Azzolina; Lydia Giannitrapani; Giuseppe Montalto; Melchiorre Cervello; Antonella Cusimano
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.